Illumina Stock Climbs 6.6 Percent After Positive Q3 Results

Oct 25, 2005

NEW YORK, Oct. 25 (GenomeWeb News) - Shares in Illumina were up 6.6 percent, or $.89, at $14.49 in mid-afternoon trading after the company announced positive third-quarter results yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

In Brief This Week: WuXi NextCode, 10x Genomics, Synthego, and More
People in the News: Carlos Bustamante, Douglas Berthiaume, Christopher O'Connell, and More
Food Allergy GWAS Leads to Five Susceptibility Loci
BabySeq Carrier Results Go Beyond Commercial Carrier Tests, Inform Parents' Reproductive Plans
Konica Minolta Closes Ambry Genetics Acquisition
Physical Inactivity, Poor Sleep Can Amplify Genetic Risk of Obesity

The Scan

Who Are You?

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

'Problematic'

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Republicans Take on Peer Review

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

This Week in Science

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

Main menu